Company: VRCA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0000950170-25-107358
Chunk: 10

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 6
Chunk 10
---
3) Previously filed as Exhibit 3.4 to the Company's Registration Statement on Form S-1 (File No. 333-225104), filed with the Securities and Exchange Commission on May 22, 2018. + Certain portions of this exhibit, indicated by asterisks, have been omitted pursuant to Item 601(b)(10) of Regulation S-K because they are not material and would likely cause competitive harm to the registrant if publicly disclosed.^ Pursuant to Item 601(a)(5) of Regulation S-K promulgated by the SEC, certain exhibits and schedules to this agreement have been omitted. The Company hereby agrees to furnish supplementally to the SEC, upon its request, any or all of such omitted exhibits or schedules.* These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing

32

SignaturesPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

     VERRICA PHARMACEUTICALS INC.

     August 12, 2025

     By:
      
     /s/ Jayson Rieger

     Jayson Rieger

     Chief Executive Officer and President

     (Principal Executive Officer)

     By:
      
     /s/ John J. Kirby

     John J. Kirby

     Interim Chief Financial Officer

     (Interim Principal Financial Officer)

33